UnitedHealth Group agreed to sell 8 series of notes, including Floating Rate Notes due July 15, 2026, under an Underwriting Agreement and a Pricing Agreement dated July 23, 2024. The notes mature from July 15, 2026 to July 15, 2064.

1. 01

   UnitedHealth Group agreed to sell 8 series of notes, including Floating Rate Notes due July 15, 2026, under an Underwriting Agreement and a Pricing Agreement dated July 23, 2024. The notes mature from July 15, 2026 to July 15, 2064.

2. 02

   The company agreed to sell Floating Rate Notes due July 15, 2026, in an aggregate principal amount of $500,000,000, and 4.750% notes in an aggregate principal amount of $650,000,000. It said 4.800% notes due January 15, 2030, are in an aggregate principal amount of $1,250,000,000.

3. 03

   The company agreed to sell 4.950% notes due January 15, 2032, in an aggregate principal amount of $1,500,000,000; 5.150% notes due July 15, 2034, in an aggregate principal amount of $2,000,000,000; 5.500% notes due July 15, 2044, in an aggregate principal amount of $1,500,000,000; 5.625% notes due July 15, 2054, in an aggregate principal amount of $2,750,000,000; and 5.750% notes due July 15, 2064, in an aggregate principal amount of $1,850,000,000.

4. 04

   The company said the notes were issued on July 25, 2024 under the Indenture dated February 4, 2008 and were registered under the Securities Act of 1933 on Form S-3 automatic shelf registration statement (File No. 333-270279).

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.